24.09 2019 . 2,6 .
GBI Research, 6? 20,7% 2019?. 2,6? . . 2012?. 750? .
, , 2?, 2012?. (Food and Drug Administration, FDA) Qsymia ( + , Vivus) Belviq (, Arena Pharmaceuticals). Xenical (, Roche). , GBI Research, ( ), ( ) .
, . 3% ; 1? ; 2 III .
, , , .
www.thepharmaletter.com; www.companiesandmarkets.com
